• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Mithridion

edit

Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer’s disease and schizophrenia.

Milestones

edit

• 
  Mithridion added Alex M. Kasper as CFO.
  Posted 5/20/11 at 5:17pm
• 
  Mithridion added Trevor M. Twose as CEO.
  Posted 5/20/11 at 5:17pm
• 
  Mithridion received $1.25M in Series C funding. (1/11/11)
  Posted 5/20/11 at 5:17pm via mithridion.com

Videos

Screenshots

edit

Sources

1. Mithridion Inc Announces New Funding and Outlines Strategy for Central Nervous System Drug Development (mithridion.com) [edit]